Summary & Overview
CPT 53260: Urethral Polyp Excision or Destruction
CPT code 53260 represents excision or destruction of a urethral polyp, typically performed to improve urinary flow and relieve urethral pain. As a focused genitourinary surgical procedure, it is relevant across outpatient surgical settings and hospital outpatient departments. Nationally, accurate coding of this procedure affects clinical documentation, facility vs. professional billing determinations, and utilization monitoring for urologic benign lesions.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Coverage policies and prior authorization requirements can vary by payer and site of service, affecting where and how the procedure is scheduled and reimbursed.
Readers will find benchmarks for use and billing patterns, summaries of payer policy themes, and clinical context that clarifies when 53260 is typically reported. The publication outlines typical sites of service, common clinical indications, and the role of this procedure within urologic care. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 53260 describes an operative procedure in which the provider excises a urethral polyp or destroys it by application of electric current (electrocautery/fulguration). The procedure is performed to improve urinary flow and relieve pain related to urethral lesions in male and female patients.
Service type: Surgical — Endoscopic/Minor Genitourinary Procedure
Typical site of service: Outpatient surgical center, hospital outpatient department, or ambulatory urology clinic
Clinical & Coding Specifications
Clinical Context
A typical patient is a 55-year-old male or female who presents with urinary obstructive symptoms such as weak stream, frequency, urgency, dysuria, or intermittent hematuria. Evaluation includes history, physical examination, urinalysis, urine culture if indicated, and cystoscopic inspection of the urethra and bladder. When a urethral polyp or benign-appearing lesion is identified on cystoscopy causing symptoms or bleeding, the provider performs excision or fulguration of the urethral polyp under local, regional, or general anesthesia. The procedure is commonly performed in an ambulatory surgery center or hospital operating room using cystoscopic instruments; intraoperative pathology (frozen or permanent) may be sent if malignancy is suspected. Postprocedural care includes observation for hematuria, urinary retention, pain control, and instructions for activity and follow-up with the urology clinic for pathology review and symptom reassessment.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work, time, or complexity substantially exceeds typical for the procedure. |
23 | Unusual anesthesia | Use when procedure performed under general anesthesia for unusual circumstances but no separate anesthesia code is reported. |